Etokimab (I-Mab Biopharma), which is optimized for common IL-33 gene polymorphisms, has completed patient recruitment in its ...

TUESDAY, Dec. 10, 2024 (HealthDay News) -- Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary disease (COPD), according to a ...

Treatment for asthma and COPD exacerbations have not changed in 50 years despite causing 3.8 million deaths worldwide a year combined.” The study is published in The Lancet Respiratory Medicine.

The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD flare-ups seen in 50 years, following promising clinical trial data.

Asthma Treatment: Study, published in The Lancet Respiratory Medicine, has revealed that a drug called benralizumab - administered as an injection - may be the breakthrough that we have been ...

Benralizumab is already in use for severe cases of asthma, but the new research suggests it can be used routinely by asthma patients which could prevent around two million attacks in the UK each ...

Study Says Benralizumab Could Treat Asthma Attacks November 29, 2024 — 03:56 pm EST Written by RTTNews.com for RTTNews -> ...

Benralizumab, a monoclonal antibody, is already used for the long-term management of eosinophilic asthma, with studies still evaluating the effect for long-term management in eosinophilic COPD.

Benralizumab is the first treatment for asthma attacks and chronic obstructive pulmonary disease (COPD) in 50 years. The drug, which is delivered by an injection, helps to treat flare-ups of the ...

“Treatment for asthma and COPD exacerbations have not changed in 50 years, despite causing 3.8 million deaths worldwide a year combined. “Benralizumab is a safe and effective drug already used ...

A new treatment for asthma attacks is being described as “game-changing” by the London scientists who created it. The drug, which is called benralizumab, is the first new treatment for asthma attacks ...